• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

A Parable of a Familiar Industry

Article

Once upon a time, there was an industry which provided a highly useful and in-demand set of products and services. Virtually all members of society sooner or later made use of the industry, and most would be repeat customers. The industry steadily grew, increasing both the variety and sophistication of its offerings.

Once upon a time, there was an industry which provided a highly useful and in-demand set of products and services. Virtually all members of society sooner or later made use of the industry, and most would be repeat customers. The industry steadily grew, increasing both the variety and sophistication of its offerings.

Due to near-universal demand for the industry’s goods and services, insurance companies developed to profitably position themselves as middlemen between the industry and its customers. Government interposed itself as well, and also imposed regulations on the industry as a whole to make sure everyone behaved themselves. It became an exception, rather than the rule, for customers to directly pay for the goods and services they were receiving from the industry. As a result, prices stopped being determined by the seller and buyer, and started being set by the government and third-party insurers.

Numerous smart people put a lot of effort into calculating how much everything should be worth. Of course, payment had to exceed the cost of overhead (equipment, real estate, electricity, personnel, etc.) sufficiently to allow for a profit; otherwise, nobody would seek to go into the industry anymore.

Years went by, and times were not always good. Government was always under pressure to cut costs (so as to lower taxes or to spend more somewhere else), and the third-party insurers were always in search of ways to cut costs (so as to lower premiums or to profit more). However, reimbursements to the industry could only be cut a finite amount before eliminating the profitability of the industry’s goods and services. After all, nobody would expect an industry to operate at or below its break-even point.

As it happens, they could. And did. More of the abovementioned smart people came up with the idea that, yes, the newest cuts being proposed are such that nobody could make a profit by providing service No. 1… but the industry needn’t worry, because it can still do very well for itself by providing services No. 2 through No. 10, which have been generously permitted to remain profitable. (If it helps, you can give names instead of numbers to the services: X-rays, ultrasounds, nephrology consults, lap choles...)

The industry grumbled a bit, but endured it. It was better than fighting City Hall, after all. Also, the law prohibited most of the industry from engaging in collective bargaining, so a unified “we’re not going to take this” response was not in the cards.

Fast-forward a few governmental administrations and a few more cycles of boom and bust, accompanied by additional cost-cutting. Overhead hasn’t been reduced; in many ways it’s risen. In the meantime, cuts have rendered services No. 2 through 7 unprofitable, if not money-losers. The industry is now limping along on Nos. 8 through 10, amid a constant stream of intel that the remaining profitable ventures are being considered for the chopping-block.

Can you guess what happens next? We’re about to find out.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.